Abstract
The hypothesis that insulin-dependent diabetes mellitus (IDDM) in man results from destruction of the pancreatic beta cells by an autoimmune process was prompted by circumstantial evidence. The association of IDDM with markers of the major histocompatibility complex suggests that genetic factors are important in determining susceptibility to the disease, and indicates possible involvement of the immune system. Antibody-mediated and cell-mediated immunological phenomena are demonstrable in high-risk subjects in the pre-clinical phase, and in patients with early overt disease. The histology of the Islets of Langerhans was consistent with an inflammatory immune attack. The hypothesis was strengthened by recognition that IDDM can occur in animals as the result of an autoimmune attack on the pancreatic beta cells, and that the process in animals can be prevented by immunomodulatory interventions. On this background, and with growing experience of the use of immunosuppressive drugs in organ transplantation, clinical trials of immunotherapy early in the course of overt IDDM have been undertaken. This summary deals with the now substantial experience with Cyclosporine as the immunosuppressive agent.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Marner, B., Agner, T., Binder, C., Lernmark, A., Nerup, J., Mandrup-Oulsen, T., Walldorf, S., 1985, Increased reduction in fasting C- peptide is associated with islet cell antibodies in Type I (insulin-dependent) diabetic patients. Diabetologia 28: 875–880.
Drash, A.L., 1987, In: Clinical Care of the Diabetic Child, Year Book Medical Publications Inc., Chicago: 33–51.
Srikanta, S., Ganda, O.P., Eisenbarth, G.S., Soeldner, J.S., 1983, Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus. N Engl J Med 308: 322–325.
Dupre, J., Stiller, C.R., Gent, M., Donner, A., Graffenried, B., Murphy, G., Heinrichs, D., Jenner, M.R., Keown, P.A., Laupacis, A., Mahon, J., Martell, R., Rodger, N.W., and Wolfe, B.M., 1988, Effects of Immunosuppression with Cyclosporine in Insulin-Dependent Diabetes Mellitus of Recent Onset: The Canadian Open Study at 44 months. Transplantation Proceedings. Vol. XX, No. 3, Suppl. 4: 184–192.
Ruiz, P., Kolbech, P.C., Scroggs, M.W., Sanfilippo, F., 1988, Associations between Cyclosporine therapy and interstitial fibrosis in renal allograft biopsies. Transplantaion, 45: 91–95.
Dupre, J., Stiller, C.R., Gent, M., von Graffenried, B., Momah, C.I., Jenner, M., Wolfe, B.M., Mahon, J., Atkinson, P., 1988, Shortterm Methylprednisolone combined with nephrotoxic doses of cyclosporine induces high rates of remission in Type I diabetes. Proceedings International Confereence, Immunointervention in Autoimmune Diseases.
Assan, R., 1988, The Use of Cyclosporine in Adult Type I Diabetes. Proceedings International Conference, ImmunoIntervention in Autoimmune Diseases.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this chapter
Cite this chapter
Dupre, J., Stiller, C.R. (1988). Effects of Immunosuppression with Cyclosporine on Beta Cell Function and Clinical Remission in Very Early Overt Type I Diabetes. In: Camerini-Davalos, R.A., Cole, H.S. (eds) Prediabetes. Advances in Experimental Medicine and Biology, vol 246. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5616-5_43
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5616-5_43
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5618-9
Online ISBN: 978-1-4684-5616-5
eBook Packages: Springer Book Archive